Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet].
Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
Autoimmunity: From Bench to Bedside [Internet].
Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.
Bogota (Colombia): El Rosario University Press; 2013 Jul 18.
Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet].
Wells GA, Smith C, Hossain A, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar. (CADTH Health Technology Assessment, No. 146.)
Clinical Review Report: sarilumab (Kevzara) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 May.
Tocilizumab (Actemra): Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].
Donahue KE, Gartlehner G, Schulman ER, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. (Comparative Effectiveness Review, No. 211.)
Endotext [Internet].
Feingold KR, Anawalt B, Boyce A, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Golimumab (Simponi) IV: In Combination with Methotrexate (MTX) for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Informed Health Online [Internet].
Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Changing Health Care Systems and Rheumatic Disease.
Institute of Medicine (US) Committee on Changing Health Care Systems and Rheumatic Disease; Manning FJ, Barondess JA, editors.
Washington (DC): National Academies Press (US); 1996.
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M, Archer R, Tosh J, et al.
Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.35.)
Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis After the Failure of a Tumour Necrosis Factor Inhibitor: A Systematic Review and Economic Evaluation.
Malottki K, Barton P, Tsourapas A, et al.
Southampton (UK): NIHR Journals Library; 2011 Mar. (Health Technology Assessment, No. 15.14.)
Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition.
Walker HK, Hall WD, Hurst JW, editors.
Boston: Butterworths; 1990.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Spondyloarthritis in over 16s: diagnosis and management.
National Institute for Health and Care Excellence (UK).
London: National Institute for Health and Care Excellence (UK); 2017 Feb. (NICE Guideline, No. 65.)
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
Archer R, Hock E, Hamilton J, et al.
Southampton (UK): NIHR Journals Library; 2018 Nov. (Health Technology Assessment, No. 22.66.)
Adverse Effects of Vaccines: Evidence and Causality.
Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.
Washington (DC): National Academies Press (US); 2011 Aug 25.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on